0
Combining precise genome engineering and protein activity profiling to methodically study thousands of cancer genes, scientists were able to pinpoint promising cancer drug targets.
Combining precise genome engineering and protein activity profiling to methodically study thousands of cancer genes, scientists were able to pinpoint promising cancer drug targets.